Both Primary and Salvage HIFU Treatments Recommended in 2014 EAU Guidelines on Prostate Cancer

Strong Recognition of EDAP's HIFU Technology by France's Health Authorities

LYON, France , April 10, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation at the European Association of Urology (EAU) 2014 Annual Congress that will be held in Stockholm on April 11-15, 2014 .

Highlights Major milestones successfully achieved for Ablatherm-HIFU FDA PMA process Strong lithotripsy sales traction in the US with greater than twofold sales increase Record sales backlog of lithotripsy and HIFU devices entering 2014 LYON, France , April 3, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA

LYON, France , March 20, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has completed its response to questions from the FDA regarding the Company's Ablatherm-HIFU Pre-Market Approval ("PMA") application, closing this step

LYON, France , Feb. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland . Focal One is the first robotic HIFU device dedicated to the focal

LYON, France , Feb. 10, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2013 results announcement, which will take place on Thursday, April 3, 2014 , before the opening of the

LYON, France , Nov. 21, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today financial results for the third quarter ended September 30, 2013 . Recent Highlights Total third quarter 2013 revenue of EUR 5.6 million , sequential quarterly

LYON, France , Oct. 31, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2013 results announcement, which will take place on Thursday, November 21, 2013 , before the opening of the market.

LYON, France , Oct. 22, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer, Ablatherm-HIFU, will be featured in multiple presentations